Abstract
Chronic kidney disease (CKD) often culminates in renal failure as a consequence of progressive interstitial fibrosis and is an important cause of illness and death in dogs. Identification of disease biomarkers and gene expression changes will yield valuable information regarding the specific biological pathways involved in disease progression. Toward these goals, gene expression changes in the renal cortex of dogs with X-linked Alport syndrome (XLAS) were examined using microarray technology. Extensive changes in inflammatory, metabolic, immune, and extracellular matrix biology were revealed in affected dogs. Statistical analysis showed 133 genes that were robustly induced or repressed in affected animals relative to age-matched littermates. Altered expression of numerous major histocompatibility complex (MHC) molecules suggests that the immune system plays a significant role in XLAS. Increased expression of COL4A1 and TIMP-1 at the end stage of disease supports the suggestion that expression increases in association with progression of fibrosis and confirms an observation of increased COL4A1 protein expression. Clusterin may function as one of the primary defenses of the renal cortex against progressive injury in dogs with XLAS, as demonstrated here by increased CLU gene expression. Cellular mechanisms that function during excess oxidative stress might also act to deter renal damage, as evidenced by alterations in gene expression of SOD1, ACO1, FDXR, and GPX1. This investigation provides a better understanding of interstitial fibrosis pathogenesis, and potential biomarkers for early detection, factors that are essential to discovering more effective treatments thereby reducing clinical illness and death due to CKD.
Similar content being viewed by others
References
Baker TK, Higgins MA, Carfagna MA, Ryan TP (2003) Characterization of hepatocytes and their use as a model system in toxicogenomics. In: An Introduction to Toxicogenomics, Burczynski ME, (ed.) (Boca Raton, FL: CRC Press), pp 117–143
Baker KE, Parker R (2004) Nonsense-mediated mRNA decay; terminating erroneous gene expression. Curr Opin Cell Biol 16, 293–299
Basile DP, Martin DR, Hammerman MH (1998) Extracellular matrix related genes in kidney post-ischemic injury: potential role for TGF-B in repair. Am J Physiol Renal Physiol 275, F894–F903
Basile DP, Donohoe D, Roethe K, Osborn J (2001) Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 281, F887–F899
Basile D, Fredrich K, Weihrauch DW, Hattan N, Chilian WM (2004) Angiostatin and matrix metalloprotease expression following ischemic acute renal failure. Am J Physiol Renal Physiol 286, F893–F902
Basile DP, Fredrich K, Alausa M, Vio CP, Liang M, et al. (2005) Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure. Am J Physiol Renal Physiol 288, F953–F963
Bernard MA, Valli VE (1977) Familial renal disease in Samoyed dogs. Can Vet J 18, 181–189
Branton MH, Kopp JB (1999) TGF-beta and fibrosis. Microbes Infect 1, 1349–1365
Cox ML, Lees GE, Kashtan CE, Murphy KE (2003) Genetic cause of X-linked Alport syndrome in a family of domestic dogs. Mamm Genome 14, 396–403
Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2, 161–174
Gene Ontology Consortium (2000) Gene Ontology: tool for the unification of biology. Nat Genet 25, 25–29
Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M (2002) Meta-analysis of genotype-phrnotype correlation in X-linked Alport syndrome: impact on clinical counseling. Nephrol Dial Transplant 17, 1218–1227
Hara I, Miyake H, Gleaye ME, Kamidono S (2001) Introduction of clusterin gene into human renal cell carcinoma cells enhances their resistance to cytotoxic chemotherapy through inhibition of apoptosis both in vitro and in vivo. Jpn J Cancer Res 92, 1220–1224
Harendza S, Schneider A, Helmchen U, Stahl RA (1999) Extracellular matrix deposition and cell proliferation in a model of chronic glomerulonephritis in the rat. Nephrol Dial Transplant 14, 2873–2879
Higgins MA, Berridge BR, Mills BJ, Schultze AE, Gao H, et al. (2003) Gene expression analysis of the acute phase response using a canine microarray. Toxicol Sci 74, 470–484
Huijun W, Long C, Zhigang Z, Feng J, Muyi G (2005) Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis. Exp Mol Pathol 78, 17–24
Humes HD (1995) Acute renal failure: prevailing challenges and prospects for the future. Kidney Int Suppl 50, S26–S32
Isaka Y, Akagi Y, Ando Y, Tsujie M, Imai E (1999) Cytokines and glomerulosclerosis. Nephrol Dial Transplant 14 Suppl 1, 30–32
Kashtan CE (1998) Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol 9, 1736–1750
Kashtan CE, (2002) Animal models of Alport Syndrome. Nephrol Dial Transplant 17, 1359–1361
Kim JY, Suh KS (1995) Light microscopic and electron microscopic features of cyclosporine nephrotoxicity in rats. J Korean Med Sci 10, 352–359
Kleinman JG, Worcester EM, Beshensky AM, Sheridan AM, Bonventre JV, et al. (1995) Upregulation of osteopontin expression by ischemia in rat kidney. Ann N Y Acad Sci 760, 321–323
Klipper-Aurbach Y, Wasserman M, Braunspiegel-Weintrob N, Borstein D, Peleg S, et al. (1995) Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses 45, 486–490
Lees GE, Helman RG, Kashtan CE, Michael AF, Homco LD, et al. (1999) New form of X-linked dominant hereditary nephritis in dogs. Am J Vet Res 60, 373–383
Matsuda A, Itoh Y, Koshikawa N, Akizawa T, Yana I, et al. (2003) Clusterin, an abundant serum factor, is a possible negative regulator of MT6-MMP/MMP-25 produced by neutrophils. J Biol Chem 278, 36350–36357
Murphy BF, Kirszbaum L, Walker ID, D’Apice AJ (1988) SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. J Clin Invest 81, 1858–1864
Nakanishi K, Yoskikawa N, Iijima K, Nakamura H (1996) Expression of type IV collagen α3 and α4 chain mRNA in X-linked Alport syndrome. J Am Soc Nephrol 7, 938–945
Noiri E, Dickman K, Miller F, Romanov G, Romanov VI, et al. (1999) Reduced tolerance to acute renal ischemia in mice with a targeted disruption of the osteopontin gene. Kidney Int 56, 74–82
Padanilam BJ, Martin DR, Hammerman MR (1996) Insulin-like growth factor I-enhanced renal expression of osteopontin after acute ischemic injury in rats. Endocrinology 137, 2133–2140
Pennie WD (2000) Use of cDNA microarrays to probe and understand the toxicological consequences of altered gene expression. Toxicol Lett 112–113, 473–477
Persy VP, Verhulst A, Ysebaert DK, De Greef KE, De Broe ME (2003) Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney Int 63, 543–553
Rao VH, Lees GE, Kashtan CE, Nemori R, Singh RK, et al. (2003) Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS). Kidney Int 63, 1736–1748
Rao VH, Lees GE, Kashtan CE, Delimont DC, Singh R, et al. (2005) Dysregulation of renal MMP-3 and MMP-7 in canine X-linked Alport syndrome. Pediatr Nephrol 20, 732–739
Rheault MN, Kren SM, Thielen BK, Mesa HA, Crosson JT, et al. (2004) J Am Soc Nephrol 15, 1466–1474
Rosenberg ME, Girton R, Finkel D, Chmielewski D, Barrie A, et al. (2002) Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging. Mol Cell Biol 22, 1893–1902
Sampson NS, Ryan ST, Enke DA, Cosgrove D, Koteliansky V, et al. (2001) Global gene expression analysis reveals a role for the alpha 1 integrin in renal pathogenesis. J Biol Chem 276, 34182–34188
Saunders JR, Aminian A, McRae JL, O’Farrell KA, Adam WR, et al. (1994) Clusterin depletion enhances immune glomerular injury in the isolated perfused kidney. Kidney Int 45, 817–827
Schnaper HW, Kopp JB, Poncelet AC, Hubchak SC, Stetler-Stevenson WG, et al. (1996) Increased expression of extracellular matrix proteins and decreased expression of matrix proteases after serial passage of glomerular mesangial cells. J Cell Sci 109, 2521–2528
Schwochau GB, Nath KA, Rosenberg ME (1998) Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties. Kidney Int 53, 1647–1653
Shinoura N, Heffelfinger SC, Miller M, Shamraj OI, Miura NH, et al. (1994) RNA expression of complement regulatory proteins in human brain tumors. Cancer Lett 86, 143–149
Thorner PS, Zheng K, Kalluri R, Jacobs R, Hudson BG (1996) Coordinate gene expression of the α3, α4, and α5 chains of collagen type IV: evidence from a canine model of X-linked neprhitis with a COL4A5 mutation. J Biol Chem 271, 13821–13828
Uchio K, Manabe N, Tamura K, Miyamoto M, Yamaguchi M, et al. (2000) Decreased matrix metalloproteinase activity in the kidneys of hereditary nephritic mice (ICGN strain). Nephron 86, 145–151
Vogel KG, Paulsson M, Heinegard D (1984) Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 223, 587–597
Weber IT, Harrison RW, Iozzo RV (1996) Model structure of decorin and implications for collagen fibrillogenesis. J Biol Chem 271, 31767–31770
Winnemoller M, Schmidt G, Kresse H (1991) Influence of decorin on fibroblast adhesion to fibronectin. Eur J Cell Biol 45, 10–17
Yamada Y, Ichihara S, Izawa H, Tanaka M, Yokota M (2001) Association of a G994 → T (Val279 → Phe) polymorphism of the plasma platelet-activating factor acetylhydrolase gene with myocardial damage in Japanese patients with nonfamilial hypertrophic cardiomyopathy. J Hum Genet 46: 436–441
Zheng K, Thorner PS, Marrano P, Beumal R, McInnes R (1994) Canine X chromosome-linked hereditary nephritis: a genetic model for human X-linked hereditary nephritis resulting from a single base mutation in the gene encoding the alpha 5 chain of collagen type IV. Proc Natl Acad Sci USA 91, 3989–3993
Acknowledgments
This work was supported by grants from the College of Veterinary Medicine Signature Programs Enhancement Initiative and the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Greer, K.A., Higgins, M.A., Cox, M.L. et al. Gene expression analysis in a canine model of X-linked Alport syndrome. Mamm Genome 17, 976–990 (2006). https://doi.org/10.1007/s00335-005-0179-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00335-005-0179-8